Suppr超能文献

小剂量的舒必利可阻断多巴胺激动剂对饮水的抑制作用及对镇静的诱导作用。

Suppression of drinking and induction of sedation by a dopamine agonist is blocked by small doses of spiperone.

作者信息

Dourish C T, Cooper S J

出版信息

Neuropharmacology. 1982 Jan;21(1):69-72. doi: 10.1016/0028-3908(82)90213-1.

Abstract

ET 495 (piribedil) produced significant hypodipsia in thirsty rats at 5 and 20 mg . kg-1, the effect being greater at the lower dose. At 5 mg . kg-1 ET 495 also induced a significant sedating effect, a characteristic of small doses of dopamine agonists. Both the hypodipsic and sedating effects of ET 495 were completely reversed by pretreatment with spiperone. The slight hypodipsia produced at 20 mg . kg-1 was accompanied by signs of low intensity behavioural stereotypy. The stereotypy, unlike the other behavioural effects of ET 495 treatment, was not antagonized by spiperone pretreatment.

摘要

ET 495(吡贝地尔)在5和20毫克·千克-1剂量时可使口渴大鼠出现显著的饮水减少,低剂量时作用更强。在5毫克·千克-1时,ET 495还产生显著的镇静作用,这是小剂量多巴胺激动剂的一个特征。ET 495的饮水减少和镇静作用均可通过舒必利预处理完全逆转。20毫克·千克-1时产生的轻微饮水减少伴有低强度行为刻板症的迹象。与ET 495治疗的其他行为效应不同,刻板症不受舒必利预处理的拮抗。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验